Company & Sponsor Intelligence
University Hospital Heidelberg
Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.
Request enterprise analysis →Indexed trials4
Recruiting0
Completed3
Countries1
Therapeutic footprint
neuro_oncologystroke
Indexed studies
NCT01584167A Randomized Trial Comparing 2 Methods for Rapid Induction of Cooling in Stroke Patients, Cold Infusions vs. EMCOOLS Flex.Pads (iCOOL 2)
stroke · GermanyPHASE2
stroke · GermanyPHASE2
NCT03158389NCT Neuro Master Match - N²M² (NOA-20)
neuro_oncology · GermanyPHASE1, PHASE2
neuro_oncology · GermanyPHASE1, PHASE2
NCT01573117A Randomized Trial Comparing 2 Methods for Rapid Induction of Cooling in Stroke Patients, Cold Infusions vs. RhinoChill (iCOOL 1)
stroke · GermanyPHASE2
stroke · GermanyPHASE2
NCT02126085Sedation vs. Intubation for Endovascular Stroke TreAtment
stroke · GermanyNA
stroke · GermanyNA
Intelligence layer updated: 2026-10-29 06:17:44.639239+00:00
Enterprise intelligence
Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.
Request comparative intelligence →